Thrivent Financial for Lutherans Purchases 1,407 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Thrivent Financial for Lutherans grew its position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 4.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,916 shares of the company’s stock after buying an additional 1,407 shares during the quarter. Thrivent Financial for Lutherans owned 0.34% of iShares U.S. Pharmaceuticals ETF worth $2,229,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in IHE. Janney Montgomery Scott LLC boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 4.1% in the 4th quarter. Janney Montgomery Scott LLC now owns 6,699 shares of the company’s stock valued at $440,000 after purchasing an additional 261 shares in the last quarter. HighTower Advisors LLC lifted its stake in iShares U.S. Pharmaceuticals ETF by 1.9% in the 4th quarter. HighTower Advisors LLC now owns 13,653 shares of the company’s stock valued at $897,000 after purchasing an additional 261 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in iShares U.S. Pharmaceuticals ETF by 11.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock valued at $253,000 after buying an additional 356 shares in the last quarter. Atala Financial Inc bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $25,000. Finally, Sequoia Financial Advisors LLC increased its holdings in shares of iShares U.S. Pharmaceuticals ETF by 19.1% during the fourth quarter. Sequoia Financial Advisors LLC now owns 3,433 shares of the company’s stock worth $226,000 after buying an additional 550 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Down 0.3 %

NYSEARCA IHE opened at $68.56 on Friday. The company has a market cap of $603.33 million, a price-to-earnings ratio of 25.04 and a beta of 0.63. iShares U.S. Pharmaceuticals ETF has a twelve month low of $62.68 and a twelve month high of $73.28. The business’s fifty day moving average is $70.15 and its 200 day moving average is $69.27.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.